MedTrace Logo

Premenstrual Syndrome and Physical Activity Self-Worth

NCT05692479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-03-23

No results posted yet for this study

Summary

Premenstrual syndrome (PMS) negatively affects the quality of life of millions of women. PMS is a common cyclic disorder characterized by somatic, cognitive, emotional and behavioral symptoms that usually occurs in young and middle-aged women, lasts during the luteal phase of the menstrual cycle and ends with the onset of menstruation.Studies have shown that women with high PMS symptoms are more inactive. Physical activity participation in women affects a wide spectrum of self-perceptions, including knowledge, social, and emotional self-perceptions. By determining which physical, emotional, social and academic/knowledge areas are affected by women, increasing their participation in physical activity can be achieved. The subject of the study is to determine the symptom severity of women with and without premenstrual syndrome and to examine how premenstrual syndrome affects physical activity self-worth.

Conditions

  • Premenstrual Syndrome

Interventions

OTHER

Premenstrual Syndrome Scale, Women's Physical Activity Self-Worth Inventory, Descriptive data

Premenstrual Syndrome Scale, Women's Physical Activity Self-Worth Inventory, Descriptive data

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    collaborator OTHER

  • Nigde Omer Halisdemir University

    lead OTHER

Principal Investigators

  • Gürkan Demirtaş, MSc. · Niğde Ömer Halisdemir University

  • Arife Akbulut, MSc. · Ankara Yildirim Beyazıt University

  • Havva Sümeyye Eroğlu, MSc. · Gazi University

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-10
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05692479 on ClinicalTrials.gov